Causality, severity and avoidability of adverse drug reactions in children: An 11-year review
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Approximately 15% of pediatric adverse drug reactions (ADRs) were potentially avoidable. This highlights the need for better ADR documentation, pharmacovigilance, and clinician education to improve patient safety.
Area Of Science
- Pediatric pharmacology
- Drug safety and pharmacovigilance
- Hospital medicine
Background
- Adverse drug reactions (ADRs) are a significant cause of hospital admissions in children.
- These reactions contribute to increased healthcare utilization and costs.
- Understanding the characteristics of ADRs in pediatric populations is crucial for prevention.
Purpose Of The Study
- To evaluate the causality, severity, and avoidability of ADRs in hospitalized children.
- To identify common drug classes and reaction types associated with pediatric ADRs.
- To determine the proportion of ADRs that could have been prevented.
Main Methods
- Retrospective cohort study of 599 children (0-18 years) over 11 years.
- Exclusion of intentional drug misuse or overdose cases.
- Assessment of causality (Naranjo criteria), severity (Hartwig scale), and avoidability (Modified Schumock and Thornton scale).
- Categorization of ADRs into Type A (dose-related) and Type B (idiosyncratic).
Main Results
- Most ADRs (74%) were mild; 15% were potentially avoidable.
- Antimicrobials (46%) and analgesics (9%) were most frequently implicated.
- Type B (idiosyncratic) reactions (56%) were more common than Type A (dose-related) reactions (44%).
- Avoidable ADRs resulted from unconsidered allergies, incorrect dosing, drug interactions, or lack of preventative measures.
Conclusions
- One in six pediatric ADRs were potentially avoidable, indicating significant room for improvement.
- Enhanced ADR documentation, robust pharmacovigilance systems, and targeted clinician education are essential.
- Implementing preventative strategies can reduce the burden of ADRs in hospitalized children.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...